Perfuse_phase_II_glaucoma_thumbnail
June 27, 2025

Perfuse Therapeutics Shares Promising Phase IIa Results in Glaucoma and Diabetic Retinopathy

Could better blood flow be the key to treating glaucoma and diabetic retinopathy? New findings suggest it just might. Sometimes…

Dream OCT
May 16, 2025

Intalight’s DREAM OCT Platform Cleared for EU Market with CE Mark

DREAM OCT scans from cornea to vitreous in one single scan, enabling full anterior segment imaging. Intalight (Shanghai, China), a…

Discover our fascinating content at issuu

explore